This bill directs New Jersey's Department of Children and Families to improve access to mental health care for children and their families. It requires the department to expand services through the New Jersey Pediatric Psychiatry Collaborative, which includes adding telehealth options, providing real-time psychiatric support to pediatric doctors, and offering better training and referral systems. The legislation also mandates greater transparency by setting specific performance goals for service providers, making contract results public, and launching a public awareness campaign to help families find care. Additionally, the bill establishes a new requirement for hospitals and clinics to report standardized data on how often children seek psychiatric or behavioral health services.
This bill requires all corn masa flour and wet corn masa products sold in New Jersey to be fortified with folic acid to help reduce the risk of neural tube defects, which disproportionately affect Latino communities. Manufacturers must add specific amounts of folic acid to dry flour and wet products and clearly label these ingredients on nutrition facts panels. The law allows the state health commissioner to grant exemptions for specific products or companies if necessary. By making these changes, the legislation aims to ensure that dietary staples common in Central and South American cuisines provide essential nutritional benefits comparable to other fortified grains.
This New Jersey bill mandates that health insurance plans and Medicaid cover medically necessary tests and FDA-approved treatments designed to slow the progression of Alzheimer's disease and related disorders. The law applies to hospital service, medical service, and health service corporation contracts, as well as individual and group health insurance policies issued or renewed in the state. A key provision ensures that these specific Alzheimer's treatments are not subject to step therapy requirements, meaning patients can access them without needing to try other medications first. Additionally, the coverage must be provided at the same level as benefits for other medical conditions.
This bill permanently extends pay parity for telemedicine and telehealth services in New Jersey, requiring health insurance carriers to reimburse providers at the same rates as in-person care. It directly affects insurance companies, healthcare providers, and patients by mandating that out-of-pocket costs like deductibles and copayments for virtual visits cannot exceed those for in-person appointments. The legislation also prohibits insurers from restricting telehealth platforms, limiting service locations, or denying coverage for routine remote monitoring if the same care would be covered in person. Additionally, carriers must continue to allow patients to choose between in-person and virtual care rather than forcing telehealth as a substitute.
This bill expands New Jersey's regulation of health care service firms by requiring employment agencies and other entities that place individuals in personal residences to register as Health Care Service Firms if they provide companion, health care, or personal care services to people with disabilities or those age 60 and older. The law mandates that registered firms obtain accreditation from a recognized body within 12 months and submit annual financial statements to the Division of Consumer Affairs, with larger firms required to undergo external audits every three years or annually if gross income exceeds $10 million. Smaller firms receiving less than $500,000 in Medicaid Personal Care Assistance services must submit annual reports detailing insurance coverages and internal management practices instead of full audits. These provisions apply regardless of whether the firm uses direct employment, online platforms, or other business models to connect service providers with clients.
This bill (A 3434) requires New Jersey dialysis centers to allow patients receiving treatment to be accompanied by a designated support person who can assist with communication, mobility, and care decisions. It directly affects dialysis patients and the centers providing their treatment. Centers must create and display clear written policies for support person access, implement reasonable health/safety rules (without unnecessary restrictions), and train staff on these policies. The New Jersey Department of Health will enforce the law, investigate complaints about denied access, and impose penalties for non-compliance. The law takes effect immediately upon passage.
This bill requires health insurance plans in New Jersey to continue covering adult children with disabilities who are 26 or older, provided they cannot work due to a physical or intellectual disability and are financially dependent on their parent. It amends existing law to extend coverage beyond the standard age limit of 26 for this specific group, ensuring they maintain health insurance through their parent's plan. The bill prohibits denial of coverage based on factors like marriage, having a child, or school status, which commonly affected young adults with disabilities. This change directly impacts young adults with disabilities in New Jersey who would otherwise lose coverage at age 26 but meet the eligibility criteria.
This bill requires social media platforms with significant user activity in New Jersey to display prominent warning labels about mental health risks during account sign-up and when users access certain features. It specifically targets platforms that allow social interaction (like profile creation and content sharing) and directly affects minors under 18, as defined by the bill. The warnings must highlight risks identified by the U.S. Surgeon General, including links between heavy social media use and increased depression, anxiety, and sleep disruption in youth. Platforms must comply with these labeling requirements to inform users and families about potential harms. The bill does not impose additional restrictions beyond the warning labels.
This bill would require New Jersey Medicaid to cover ovulation-enhancing drugs and related medical services without restrictions for beneficiaries experiencing infertility. It directly affects low-income New Jersey residents enrolled in Medicaid who seek infertility treatment. The key provision amends Medicaid law to explicitly include these services as a standard benefit, removing prior authorization requirements. This change would expand current coverage to ensure these treatments are accessible as routine care for eligible individuals.
This bill exempts drug manufacturers and distributors from New Jersey's pharmacy licensing requirements when distributing dialysate drugs and devices used for home dialysis treatment of end-stage renal disease patients. It directly affects dialysis manufacturers, distributors, and patients receiving home dialysis, allowing them to bypass standard pharmacy licensing rules under six specific conditions. Key provisions include requiring FDA approval, direct delivery only upon physician orders, original sealed packaging, and mandatory weekly quality checks by a consultant pharmacist. The law ensures these products are handled safely while streamlining access for patients needing home dialysis.
